Celegene, Pharmacyclics Lead Biotech Short Interest Trend (CELG, MDVN, PCYC)

By: via Benzinga
After largely shying away in the previous period, short sellers found renewed interest in many of the leading biotech and emerging ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.